Suppression of renin-angiotensin system and cancer therapy (discussion)

Nihon Rinsho. 2010 Jun;68(6):1177-85.
No abstract available

MeSH terms

  • Angiotensin II / physiology
  • Angiotensin II Type 1 Receptor Blockers / administration & dosage*
  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage*
  • Benzimidazoles / administration & dosage*
  • Benzimidazoles / therapeutic use
  • Biphenyl Compounds
  • Cimetidine / administration & dosage
  • Cyclooxygenase 2 Inhibitors / administration & dosage
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Drug Combinations
  • Drug Therapy, Combination
  • Gemcitabine
  • Humans
  • Hypertension / drug therapy
  • Hypertension / etiology
  • Interferon-alpha / administration & dosage
  • Life Style
  • Neoplasms / drug therapy*
  • Neoplasms / etiology*
  • Oxonic Acid / administration & dosage
  • Renin-Angiotensin System* / physiology
  • Tegafur / administration & dosage
  • Tetrazoles / administration & dosage*
  • Tetrazoles / therapeutic use

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Benzimidazoles
  • Biphenyl Compounds
  • Cyclooxygenase 2 Inhibitors
  • Drug Combinations
  • Interferon-alpha
  • Tetrazoles
  • Deoxycytidine
  • Angiotensin II
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid
  • Cimetidine
  • candesartan
  • Gemcitabine